|
Delayed
Nasdaq
00:44:07 21/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.590 USD | -1.89% |
|
+1.17% | -70.73% |
| Market Cap | 26.35M 22.56M 21.05M 19.31M 36.29M 2.52B 37M 250M 97.33M 1.26B 98.92M 96.77M 4.18B | P/E 2026 * |
-0.69x | P/E 2027 * | -0.84x |
|---|---|---|---|---|---|
| Enterprise Value | 26.35M 22.56M 21.05M 19.31M 36.29M 2.52B 37M 250M 97.33M 1.26B 98.92M 96.77M 4.18B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
97.3% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Atossa Therapeutics, Inc.
| 1 day | -2.08% | ||
| 1 week | +1.17% | ||
| Current month | +25.12% | ||
| 1 month | +4.02% | ||
| 3 months | -46.49% | ||
| 6 months | -38.48% | ||
| Current year | -70.73% |
| 1 week | 2.43 |  | 2.97 |
| 1 month | 2.05 | | 2.97 |
| Current year | 1.7 | | 10.95 |
| 1 year | 1.7 | | 19.35 |
| 3 years | 1.7 | | 34.65 |
| 5 years | 1.7 | | 64.65 |
| 10 years | 1.7 | | 715.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 75 | 01/04/2009 |
Mark Daniel
DFI | Director of Finance/CFO | 50 | 14/10/2025 |
Janet Rose Rea
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Quay
CHM | Chairman | 75 | 01/04/2009 |
Shu-Chih Chen
BRD | Director/Board Member | 64 | 01/04/2009 |
Stephen Galli
BRD | Director/Board Member | 79 | 01/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 20/1/26 | Free | Chief Executive Officer | 1,281,674 | 0.9922% | ||
| 20/1/26 | Ensisheim Partners LLC
| Other | Company | 0 | 0% | |
| 14/10/25 | Free | Chief Financial Officer | 578,000 | 0.4595% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.89% | +1.17% | -76.62% | -81.16% | 26.35M | |
| +1.14% | +2.27% | +2.38% | +24.66% | 50.5B | |
| -2.66% | +3.83% | +480.01% | +602.14% | 46.01B | |
| -1.08% | +4.85% | +20.68% | +90.34% | 42.85B | |
| +4.03% | +7.32% | +34.97% | +20.91% | 41.03B | |
| 0.00% | -3.91% | +17.87% | +47.98% | 32.02B | |
| +2.04% | +6.63% | +33.25% | +152.28% | 16.98B | |
| -0.94% | +5.34% | - | - | 17.05B | |
| +3.06% | +3.88% | +5.81% | +35.45% | 14.3B | |
| +1.83% | +5.21% | +85.44% | +47.29% | 13.84B | |
| Average | +0.56% | +3.04% | +67.09% | +104.43% | 27.46B | |
| Weighted average by Cap. | +0.57% | +2.37% | +104.54% | +151.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -34.89M -29.88M -27.87M -25.58M -48.06M -3.34B -49.01M -331M -129M -1.67B -131M -128M -5.54B | -38.03M -32.56M -30.38M -27.87M -52.38M -3.64B -53.41M -360M -140M -1.82B -143M -140M -6.04B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | US$2.590 | -1.89% | 59,456 |
| 19/08/26 | US$2.640 | +1.93% | 62,197 |
| 18/08/26 | US$2.590 | -7.17% | 58,563 |
| 17/08/26 | US$2.790 | +7.31% | 192,438 |
| 14/08/26 | US$2.600 | +1.56% | 96,120 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATOS Stock
Select your edition
All financial news and data tailored to specific country editions
